Eagle Ridge Investment Management’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
$662K Hold
1,600
0.06% 86
2024
Q3
$808K Hold
1,600
0.07% 79
2024
Q2
$780K Hold
1,600
0.07% 79
2024
Q1
$864K Hold
1,600
0.08% 78
2023
Q4
$888K Hold
1,600
0.09% 78
2023
Q3
$700K Sell
1,600
-117
-7% -$58.3K 0.08% 84
2023
Q2
$862K Sell
1,717
-83
-5% -$39.8K 0.09% 79
2023
Q1
$900K Buy
+1,800
New +$861K 0.1% 77

Other funds holding IDXX

Eagle Ridge Investment Management's IDXX Position: Q4 2024 in Review

Eagle Ridge Investment Management held its Idexx Laboratories (IDXX) position steady in Q4 2024 at 1,600 shares worth $662K. The position accounts for 0.06% of the portfolio, ranked #86.

Eagle Ridge Investment Management first reported a position in IDXX in Q1 2023 and has held it in 8 quarters since. The position peaked at $900K in Q1 2023. 1,123 funds tracked by Wall St. Rank hold IDXX as of Q4 2024.

  • Eagle Ridge Investment Management held 1,600 shares of Idexx Laboratories worth $662K as of Q4 2024.
  • Eagle Ridge Investment Management left its Idexx Laboratories share count unchanged in Q4 2024.
  • Idexx Laboratories made up 0.06% of Eagle Ridge Investment Management's portfolio in Q4 2024, its #86 holding.
  • Eagle Ridge Investment Management first reported a position in Idexx Laboratories in Q1 2023 and has held it in 8 quarters since.
  • Eagle Ridge Investment Management's Idexx Laboratories position peaked at $900K in Q1 2023.
  • 1,123 funds tracked by Wall St. Rank held Idexx Laboratories as of Q4 2024.

Based on Eagle Ridge Investment Management's 13F filing for Q4 2024, filed 27 Jan 2025.